Zhang Huijuan, Ji Yandan, Chen Qianqian, Zhu Xing, Zhang Xiaoge, Tan Zhiyuan, Tian Qianqian, Yang Xiangbo, Zhang Zhenzhong
School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China Collaborative Innovation Center of New Drug Research and Safety Evaluation, Zhengzhou, China.
School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China.
J Biomater Appl. 2016 Oct;31(4):568-581. doi: 10.1177/0885328216656098. Epub 2016 Jun 22.
To achieve tumor-specific delivery of doxorubicin, TiO@FeO/PEI/delivery of doxorubicin conjugates were designed and synthesized. FeO could act as magnetically responsive carriers and enhance the visible light photodynamic activities of TiO Delivery of doxorubicin was conjugated via coordination bond. The drug release rate at pH 5.2 was much faster than that at pH 7.4, due to pH-sensitive coordination bond. Besides, TiO@FeO/PEI/delivery of doxorubicin showed high antitumor efficacy combining with phototherapy, good bio-safety, higher cellular uptake with an external magnetic field, and less toxicity in vitro and in vivo. These results suggested that TiO@FeO/PEI/delivery of doxorubicin may be promising for high tumor treatment efficacy with minimal side effects in future.
为实现阿霉素的肿瘤特异性递送,设计并合成了TiO@FeO/PEI/阿霉素缀合物。FeO可作为磁响应载体,增强TiO的可见光光动力活性。阿霉素通过配位键进行缀合。由于pH敏感的配位键,在pH 5.2时的药物释放速率比在pH 7.4时快得多。此外,TiO@FeO/PEI/阿霉素在联合光疗时显示出高抗肿瘤疗效、良好的生物安全性、在外部磁场作用下更高的细胞摄取率以及体内外更低的毒性。这些结果表明,TiO@FeO/PEI/阿霉素未来在以最小副作用实现高肿瘤治疗效果方面可能具有前景。